Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep;32(9):6467-6476.
doi: 10.1245/s10434-025-17736-5. Epub 2025 Jul 7.

The Landmark Series: Neoadjuvant Therapy for Resectable Pancreatic Cancer

Chelsea F Cardell  1 , Esther N Dekker  1   2 , Matthew H G Katz  1 , Ching-Wei D Tzeng  3
Affiliations
Review

The Landmark Series: Neoadjuvant Therapy for Resectable Pancreatic Cancer

Chelsea F Cardell et al. Ann Surg Oncol. 2025 Sep.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a malignancy with limited 5-year overall survival, but recent advances in maximizing chemotherapy delivery has offered some improvement across all stages. Delivery of induction chemotherapy for localized PDAC has several putative benefits, including early treatment of occult metastases, pragmatically ensuring all patients receive systemic therapy, and improved R0 resection rates. While neoadjuvant therapy has become widely accepted in borderline resectable clinical stage, its role in patients with resectable disease is less clear. This Landmark Series article discusses key studies informing the ongoing debate about neoadjuvant therapy for resectable PDAC, both published and ongoing.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors declare that they have no conflict of interest.

Similar articles

See all similar articles

References

    1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49.
    1. Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851–62.
    1. Sohal DP, Walsh RM, Ramanathan RK, Khorana AA. Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy. J Natl Cancer Inst. 2014;106(3):dju011.
    1. Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008–20.
    1. Khorana AA, McKernin SE, Berlin J, Hong TS, Maitra A, Moravek C, et al. Potentially curable pancreatic adenocarcinoma: ASCO clinical practice guideline update. J Clin Oncol. 2019;37(23):2082–8.

MeSH terms

LinkOut - more resources